Clinical Pharmacogenetics Implementation Consortium
An international consortium interested in facilitating the use of pharmacogenetic tests for improving patient care.
An international consortium interested in facilitating the use of pharmacogenetic tests for improving patient care.
Clinical Pharmacogenetics Implementation Consortium (CPIC®) is an international consortium dedicated to facilitating the use of pharmacogenetic tests to improve patient care. Founded in 2009, CPIC aims to overcome the challenge of translating genetic laboratory test results into actionable prescribing decisions for affected drugs in clinical settings. The consortium achieves this by creating, curating, and providing freely available, peer-reviewed, evidence-based, updatable, and detailed gene/drug clinical practice guidelines. This initiative is backed by a $5.00M grant investment from the National Institutes of Health, dated 01 February 2019. CPIC's efforts have led to the indexing of their guidelines in PubMed as clinical guidelines, endorsements by ASHP and ASCPT, and references in ClinGen and PharmGKB. The organization's impact spans the biotechnology, healthcare, and pharmaceutical industries, with its headquarters based in the United States. Through these endeavors, CPIC is shaping the landscape of pharmacogenetics and its integration into clinical practice on a global scale.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $5.00M | 1 | National Institutes of Health | 01 Feb 2019 |
No recent news or press coverage available for Clinical Pharmacogenetics Implementation Consortium.
We care about your data, and we'd love to use cookies make your experience better.
